EUCTR2020-005521-84-NL进行中（未招募）1 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucel
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •All subjects who received cilta-cel in a Company-sponsored clinical study are candidates for Study MMY4002. The inclusion criteria for the study are described below:
- •1. Subjects who have received at least one dose of cilta-cel in a Company-sponsored clinical study.
- •2. Subjects who have provided informed consent for Study MMY4002.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 300
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 100
排除标准
- •No exclusion criteria are applicable in this study.
研究者
相似试验
招募中
1 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene AutoleucelMedDRA version: 21.0Level: LLTClassification code: 10028228Term: Multiple myeloma Class: 10029104Multiple MyelomaCTIS2023-505530-10-00Janssen - Cilag International365
进行中（未招募）
1 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene AutoleucelMultiple MyelomaEUCTR2020-005521-84-ESJanssen-Cilag International NV400
尚未招募
4 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucelplasma cell myeloma10040778Multiple MyelomaNL-OMON53393Janssen-Cilag International NV6
招募中
3 期
A Long-term Study for Participants Previously Treated with Ciltacabtagene AutoleucelMultiple MyelomaJPRN-jRCT2033220220Ei Fujikawa228
进行中（未招募）
1 期
ong term follow-up study of gene therapy trial for X-linked Retinitis PigmentosaEUCTR2018-000425-31-Outside-EU/EEAJanssen-Cilag International NV